Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sophia Genetics SA - SIC # 7372 - PREPACKAGED SOFTWARE
Ticker
Exchange
SIC #
Website
Latest Ticker
SOPH
Nasdaq
7372
https://www.sophiagenetics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sophia Genetics SA
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
- Mar 20th, 2024 2:00 pm
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
- Mar 15th, 2024 10:00 am
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
- Mar 9th, 2024 1:17 pm
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
- Mar 7th, 2024 5:07 pm
SOPHiA GENETICS Full Year 2023 Earnings: EPS Misses Expectations
- Mar 6th, 2024 6:41 pm
SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2023 Earnings Call Transcript
- Mar 6th, 2024 1:31 pm
Q4 2023 Sophia Genetics SA Earnings Call
- Mar 6th, 2024 8:15 am
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
- Mar 5th, 2024 11:45 am
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
- Feb 22nd, 2024 1:45 pm
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
- Feb 20th, 2024 3:46 pm
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
- Feb 7th, 2024 12:39 pm
SOPHiA GENETICS SA's (NASDAQ:SOPH) top owners are retail investors with 46% stake, while 26% is held by institutions
- Feb 5th, 2024 10:14 am
SOPHiA GENETICS Supports Genetic Testing in Brazil
- Jan 25th, 2024 3:50 pm
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
- Jan 18th, 2024 8:00 pm
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
- Jan 15th, 2024 4:00 am
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 10th, 2024 10:15 pm
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics
- Jan 8th, 2024 2:08 pm
Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders
- Dec 21st, 2023 12:00 pm
SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
- Dec 14th, 2023 5:43 pm
SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings
- Dec 7th, 2023 2:01 pm
Scroll